COMPASS Pathways plc (NASDAQ:CMPS) has caught the attention of institutional investors who hold a sizeable 29% stake

In This Article:

Key Insights

To get a sense of who is truly in control of COMPASS Pathways plc (NASDAQ:CMPS), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 29% to be precise, is institutions. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.

In the chart below, we zoom in on the different ownership groups of COMPASS Pathways.

Check out our latest analysis for COMPASS Pathways

ownership-breakdown
NasdaqGS:CMPS Ownership Breakdown November 25th 2024

What Does The Institutional Ownership Tell Us About COMPASS Pathways?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

As you can see, institutional investors have a fair amount of stake in COMPASS Pathways. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at COMPASS Pathways' earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
NasdaqGS:CMPS Earnings and Revenue Growth November 25th 2024

It would appear that 13% of COMPASS Pathways shares are controlled by hedge funds. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. Our data shows that George Goldsmith is the largest shareholder with 11% of shares outstanding. With 10% and 7.9% of the shares outstanding respectively, Atai Life Sciences N.V. and Citadel Advisors LLC are the second and third largest shareholders.

We did some more digging and found that 9 of the top shareholders account for roughly 52% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.